NHS leaders have warned that the cost of supporting people with ADHD and autism is becoming “out of control,” as services across England continue to face rising demand and mounting pressure on budgets. The warning comes amid fresh concern that local health systems are struggling to keep pace with referrals, assessments and long-term support needs.
Growing pressure on services and budgets
The BMJ reported on September 1, 2026, that NHS leaders raised the alarm over the scale of spending linked to ADHD and autism, describing the situation as increasingly difficult to manage. The concern reflects a broader pattern of demand that has accelerated across mental health and neurodevelopmental services, where waiting times and workforce shortages remain persistent problems.
Health leaders are now facing difficult choices about how to balance access, quality and affordability while trying to support more patients who need assessment, treatment and follow-up care. The issue is particularly sensitive because delays in diagnosis can affect education, employment and family life, while under-resourcing can leave clinicians unable to meet need effectively.
A wider NHS challenge, not an isolated one
The warning over ADHD and autism spending sits alongside a wider set of pressures reported by The BMJ, including concerns about staffing, service delivery and the sustainability of NHS provision. On the same news page, other recent stories highlighted strain across the health system, suggesting that neurodevelopmental care is becoming part of a larger debate about how the NHS allocates limited resources.
That broader context matters because ADHD and autism support often involves multiple parts of the health system, from initial referral pathways to specialist assessment and community follow-up. As demand grows, the challenge for NHS leaders is not only funding, but also ensuring that services are organised well enough to deliver timely care.
What the warning means for patients
For patients and families, the warning may add urgency to long-running concerns about access and consistency. Rising costs do not automatically mean reduced care, but they can intensify pressure on commissioners and service providers to prioritise faster, more efficient pathways. In practical terms, that could influence how referrals are triaged, how assessments are delivered, and how support is offered after diagnosis.
With demand still increasing, the debate is likely to continue over how the NHS should respond: whether through more investment, redesigned services, or a stronger focus on early intervention and community support. For now, the latest warning underscores a familiar message in English healthcare — need is growing faster than the system’s capacity to absorb it.
Source: The BMJ News
Photo source: AI-generated or edited image
